Viracta Therapeutics | 3:首次持股聲明-高管 Burcar Melody
Viracta Therapeutics | 4:持股變動聲明-高管 Rothera Mark
Viracta Therapeutics | 4:持股變動聲明-高管 Cohen Darrel P.
Viracta Therapeutics | 4:持股變動聲明-高管 Chevallard Daniel R.
Viracta Therapeutics | 4:持股變動聲明-董事 ROYSTON IVOR
Viracta Therapeutics | 4:持股變動聲明-董事 Pomerantz Roger
Viracta Therapeutics | 4:持股變動聲明-高管 Chevallard Daniel R.
Viracta Therapeutics | SC 13G:超過5%持股股東披露文件-Forward Ventures V, L.P.(6.65%)
Viracta Therapeutics | 4:持股變動聲明-高管 Rothera Mark
Viracta Therapeutics | 4:持股變動聲明-高管 Chevallard Daniel R.
Viracta Therapeutics | 4:持股變動聲明-董事 ROYSTON IVOR
Viracta Therapeutics | 4:持股變動聲明-董事 Pomerantz Roger
Viracta Therapeutics | 4:持股變動聲明-董事 ROYSTON IVOR
Viracta Therapeutics | 4:持股變動聲明-董事 Pomerantz Roger
Viracta Therapeutics | 4:持股變動聲明-高管 Chevallard Daniel R.
Viracta Therapeutics | 4:持股變動聲明-董事 Pomerantz Roger
Viracta Therapeutics | 4:持股變動聲明-高管 Cohen Darrel P.
Viracta Therapeutics | 3:首次持股聲明-高管 Cohen Darrel P.
Viracta Therapeutics | 4:持股變動聲明-董事 Simon Barry J.
Viracta Therapeutics | 4:持股變動聲明-董事 Rubino Stephen
暫無數據